Gulf Pharmaceutical Industries P.S.C. Company Description

Gulf Pharmaceutical Industries P.S.C., together with its subsidiaries, manufactures and sells medicines, drugs, and various other types of pharmaceutical, cosmetic, and medical compounds in United Arab Emirates, other GCC countries, and internationally.

The company operates through Manufacturing, Trading, Investments, and Others segment. It offers generic medicines for pain and inflammation, antiviral, respiratory, anti-infectives, immunosuppressants and selective immunosuppressants, cardio care, CNS and psychiatry, vitamins and supplements, wound care management, dermatology, endocrine, gynecology and women care, anemia, antibiotics, decongestants and other nasal preparations, hyperkalemia and hyperphosphatemia, urinary antispasmodics, erectile dysfunction, benign prostatic hyperplasia, and gastrointestinal tract.

The company is also involved in transportation activities; general trading; distribution, wholesale, and retail trading of medicines and cosmetic products; facilities management services, health treatment undertaking services, and hospitals management; investment in commercial, industrial, and healthcare enterprises; agent; sale of cosmetics; export and import activities; and trading in medical equipment.

Gulf Pharmaceutical Industries P.S.C. was incorporated in 1980 and is headquartered in Ras al-Khaimah, the United Arab Emirates.

Gulf Pharmaceutical Industries P.S.C.

Country	United Arab Emirates
Founded	1980
Industry	Pharmaceutical Preparations
Employees	2,400
CEO	Basel Nimer Ziyadeh

Contact Details

Address: Airport Road Ras al-Khaimah United Arab Emirates
Phone	971 7246 1461
Website	julphar.net

Stock Details

Ticker Symbol	JULPHAR
Exchange	Abu Dhabi Securities Exchange
Fiscal Year	January - December
Reporting Currency	AED
SIC Code	2834

Key Executives

Name	Position
Basel Nimer Ziyadeh	Chief Executive Officer
Khalid Malkawi	Chief Financial Officer
Hessa Alshehhi	Head of Investor Relations